Literature DB >> 18358876

[Unilateral presentation of X-linked myotubular myopathy (XLMTM) in two out of three female carriers in a family with no affected male].

A Drouet1, E Ollagnon-Roman, N Streichenberger, V Biancalana, M Cossée, L Guilloton, P Petiot.   

Abstract

INTRODUCTION: X-linked myotubular myopathy (XLMTM), a recessive disorder, is caused by mutations affecting the myotubulatin (MTM1) gene located on the X chromosome. Most of the affected males die in the early postnatal period whereas female carriers are usually asymptomatic. CASE REPORTS: We report a family in which two females (45 and 27 years old) in two different generations, presented unilateral weakness which had worsened since adolescence, and one 48-year-old woman presented minimal symptoms. In agreement with the computed tomography and magnetic resonance imaging findings, the EMG was compatible with myopathy. Serum creatine kinase was elevated in the second patient. The histological study showed centronuclear myopathy aspects, more severe in the second patient. Both presented c.1420C>T, p.Arg474X in exon 13 of the MTM1 gene, whereas the third patients with less pronounced manifestation, had a skewed pattern of X chromosome inactivation. DISCUSSION: Symptomatic female carriers of XLMTM can present with asymmetric malformations, which must be distinguished from an autosomal-dominant centronuclear myopathy.
CONCLUSION: Unilateral presentation of weakness cannot rule out a diagnosis of myopathy. Detection of symptomatic female carriers of an X linked recessive disease, with a severe presentation in males, is important for genetic counselling.

Entities:  

Mesh:

Year:  2008        PMID: 18358876     DOI: 10.1016/j.neurol.2007.08.008

Source DB:  PubMed          Journal:  Rev Neurol (Paris)        ISSN: 0035-3787            Impact factor:   2.607


  3 in total

1.  Manifesting carriers of X-linked myotubular myopathy: Genetic modifiers modulating the phenotype.

Authors:  Lucas Santos Souza; Camila Freitas Almeida; Guilherme Lopes Yamamoto; Rita de Cássia Mingroni Pavanello; Juliana Gurgel-Giannetti; Silvia Souza da Costa; Isabela Pessa Anequini; Silvana Amanda do Carmo; Jaqueline Yu Ting Wang; Marília de Oliveira Scliar; Erick C Castelli; Paulo Alberto Otto; Edmar Zanoteli; Mariz Vainzof
Journal:  Neurol Genet       Date:  2020-09-04

2.  Adult MTM1-related myopathy carriers: Classification based on deep phenotyping.

Authors:  Benjamin T Cocanougher; Lauren Flynn; Pomi Yun; Minal Jain; Melissa Waite; Ruhi Vasavada; Jason D Wittenbach; Sabine de Chastonay; Sameer Chhibber; A Micheil Innes; Linda MacLaren; Tahseen Mozaffar; Andrew E Arai; Sandra Donkervoort; Carsten G Bönnemann; A Reghan Foley
Journal:  Neurology       Date:  2019-09-20       Impact factor: 9.910

3.  Novel findings associated with MTM1 suggest a higher number of female symptomatic carriers.

Authors:  Marco Savarese; Olimpia Musumeci; Teresa Giugliano; Anna Rubegni; Chiara Fiorillo; Fabiana Fattori; Annalaura Torella; Roberta Battini; Carmelo Rodolico; Aniello Pugliese; Giulio Piluso; Lorenzo Maggi; Adele D'Amico; Claudio Bruno; Enrico Bertini; Filippo Maria Santorelli; Marina Mora; Antonio Toscano; Carlo Minetti; Vincenzo Nigro
Journal:  Neuromuscul Disord       Date:  2016-02-17       Impact factor: 4.296

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.